CERAVE DEVELOPED WITH DERMATOLOGISTS ACNE CONTROL CLEANSER- salicylic acid gel 
L'Oreal USA Products Inc

----------

Drug Facts

Active ingredient

Salicylic acid 2%

Purpose

Acne treatment

Uses

Warnings

For external use only

When using this product

skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. if irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Inactive ingredients

water, sodium lauroyl sarcosinate, cocamidopropyl hydroxysultaine, glycerin, niacinamide, gluconolactone, sodium methyl cocoyl taurate, PEG-150 pentaerythrityl tetrastearate, xanthan gum, sodium benzoate, sodium hydroxide, hectorite, trisodium ethylenediamine disuccinate, sodium lauroyl lactylate, tetrasodium EDTA, calcium gluconate, ceramide NP, triethyl citrate, caprylyl glycol, ceramide AP, phytosphingosine, cholesterol, hydrolyzed hyaluronic acid, carbomer, benzoic acid, ceramide EOP

image of a label

image of a label

image of a label

image of a label
CERAVE DEVELOPED WITH DERMATOLOGISTS ACNE CONTROL CLEANSER 
salicylic acid gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49967-138
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Salicylic Acid (UNII: O414PZ4LPZ) (Salicylic Acid - UNII:O414PZ4LPZ) Salicylic Acid20 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
SODIUM LAUROYL SARCOSINATE (UNII: 632GS99618)  
COCAMIDOPROPYL HYDROXYSULTAINE (UNII: 62V75NI93W)  
GLYCERIN (UNII: PDC6A3C0OX)  
NIACINAMIDE (UNII: 25X51I8RD4)  
GLUCONOLACTONE (UNII: WQ29KQ9POT)  
SODIUM METHYL COCOYL TAURATE (UNII: JVL98CG53G)  
PEG-150 PENTAERYTHRITYL TETRASTEARATE (UNII: 8L4OOQ76AM)  
XANTHAN GUM (UNII: TTV12P4NEE)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
HECTORITE (UNII: 08X4KI73EZ)  
TRISODIUM ETHYLENEDIAMINE DISUCCINATE (UNII: YA22H34H9Q)  
SODIUM LAUROYL LACTYLATE (UNII: 7243K85WFO)  
EDETATE SODIUM (UNII: MP1J8420LU)  
CALCIUM GLUCONATE (UNII: SQE6VB453K)  
CERAMIDE NP (UNII: 4370DF050B)  
TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
CERAMIDE AP (UNII: F1X8L2B00J)  
PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q)  
CHOLESTEROL (UNII: 97C5T2UQ7J)  
HYALURONIC ACID (UNII: S270N0TRQY)  
CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
BENZOIC ACID (UNII: 8SKN0B0MIM)  
CERAMIDE 1 (UNII: 5THT33P7X7)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:49967-138-01237 mL in 1 TUBE; Type 0: Not a Combination Product08/11/2021
2NDC:49967-138-0210 mL in 1 TUBE; Type 0: Not a Combination Product08/11/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00608/11/2021
Labeler - L'Oreal USA Products Inc (002136794)
Establishment
NameAddressID/FEIBusiness Operations
L'OREAL USA PRODUCTS, INC.624244349manufacture(49967-138) , pack(49967-138)

Revised: 12/2023
Document Id: 420dad6a-2891-4381-bd0f-1c886fdae112
Set id: 00203b2a-74dd-45a5-977a-3ef4eb314577
Version: 2
Effective Time: 20231231
 
L'Oreal USA Products Inc